Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma

Conditions: Carcinoma, Hepatocellular Interventions: Device: 166Holmium microspheres (QuiremSpheres ®) Sponsors: Imperial College London; Terumo Europe N.V. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials